ABUS vs KEY
Arbutus Biopharma Corp (ABUS) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the ABUS and KEY stock pages for the full models.
Not investment advice.